|
|
|
|
| LEADER |
00000cam a2200000 4500 |
| 001 |
ocn990391770 |
| 003 |
OCoLC |
| 005 |
20240809213013.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
140210s2014 vtu ob 001 0 eng d |
| 040 |
|
|
|a LIP
|b eng
|e pn
|c LIP
|d OCLCO
|d E7B
|d YDXCP
|d OCLCF
|d COO
|d IDEBK
|d EBLCP
|d GGVRL
|d DEBSZ
|d OCLCQ
|d NJR
|d OCLCO
|d OCLCA
|d OCLCQ
|d COCUF
|d CNNOR
|d STF
|d LOA
|d CUY
|d MERUC
|d ZCU
|d ICG
|d OCLCO
|d K6U
|d VT2
|d U3W
|d CNCEN
|d OCLCQ
|d G3B
|d OCLCA
|d LVT
|d OCLCA
|d S8J
|d S9I
|d TKN
|d D6H
|d DKC
|d UX1
|d A6Q
|d HS0
|d UWK
|d ADU
|d UKBTH
|d UHL
|d LIP
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCQ
|
| 066 |
|
|
|c (S
|
| 019 |
|
|
|a 868960043
|a 874147582
|a 1121583431
|a 1259157745
|
| 020 |
|
|
|a 0123969832
|
| 020 |
|
|
|a 9780123969835
|
| 020 |
|
|
|a 9780123972903
|
| 020 |
|
|
|a 0123972906
|
| 020 |
|
|
|a 1306385679
|
| 020 |
|
|
|a 9781306385671
|
| 035 |
|
|
|a (OCoLC)990391770
|z (OCoLC)868960043
|z (OCoLC)874147582
|z (OCoLC)1121583431
|z (OCoLC)1259157745
|
| 037 |
|
|
|a 569818
|b MIL
|
| 050 |
|
4 |
|a TP248.65.P62 .N38 2014
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Kumbar, Sangamesh.
|
| 245 |
1 |
0 |
|a Natural and Synthetic Biomedical Polymers.
|
| 260 |
|
|
|a Burlington :
|b Elsevier Science,
|c 2014.
|
| 300 |
|
|
|a 1 online resource (421 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|6 880-01
|a Front Cover; Natural and Synthetic Biomedical Polymers; Copyright; Contents; Dedication; Contributors; Foreword; Chapter 1: Polymer Synthesis and Processing; 1.1 . Introduction; 1.2 . Types of Polymerization; 1.2.1 . Addition Polymerization; 1.2.2 . Condensation Polymerization; 1.2.3 . Metathesis Polymerization; 1.3 . Techniques of Polymerization; 1.3.1 . Solution Polymerization; 1.3.2 . Bulk (Mass) Polymerization; 1.3.3 . Suspension Polymerization; 1.3.4 . Precipitation Polymerization; 1.3.5 . Emulsion Polymerization; 1.4 . Polymers: Properties, Synthesis, and Their Biomedical Applications.
|
| 505 |
8 |
|
|a 1.4.1 . Polycaprolactone1.4.2 . Polyethylene Glycol; 1.4.3 . Polyurethane; 1.4.4 . Polydioxanone or Poly- p -Dioxanone; 1.4.5 . Polymethyl Methacrylate; 1.4.6 . Polyglycolic Acid or Polyglycolide; 1.4.7 . Polylactic Acid or Polylactide; 1.4.8 . Polylactic- co -Glycolic Acid; 1.4.9 . Polyhydroxybutyrate; 1.4.10 . Polycyanoacrylates; 1.4.11 . Polyvinylpyrrolidone; 1.4.12 . Chitosan; 1.4.13 . Gelatin; 1.4.14 . Carrageenan; 1.4.15 . Hyaluronic Acid; 1.4.16 . Xanthan Gum; 1.4.17 . Acacia Gum; 1.4.18 . Alginate; 1.5 . Processing of Polymers for Biomedical Devices.
|
| 505 |
8 |
|
|a 1.5.1 . Fabrication of Polymer Films1.5.1.1 . Solution Casting; 1.5.1.2 . Melt Pressing; 1.5.1.3 . Melt Extrusion; 1.5.1.4 . Bubble Blown Method; 1.5.2 . Spinning Industrial Polymers; 1.5.2.1 . Solution Spinning; 1.5.2.1.1 . Wet Spinning; 1.5.2.1.2 . Electrospinning; 1.5.2.1.3 . Dry Spinning; 1.5.2.1.4 . Melt Spinning; 1.5.3 . Fabrication of Shaped Polymer Objects; 1.5.3.1 . Compression Molding; 1.5.3.2 . Injection Molding; 1.5.3.3 . Reaction Injection Molding; 1.5.3.4 . Blow Molding; 1.5.3.5 . Extrusion Molding; 1.5.4 . Calendaring; 1.6 . Future Perspectives; 1.7 . Conclusions.
|
| 505 |
8 |
|
|a AcknowledgmentsReferences; Chapter 2: Hierarchical Characterization of Biomedical Polymers; 2.1 . Introduction; 2.2 . The Hierarchical Characterization Approach; 2.3 . Bulk Characterization; 2.3.1 . Thermal Properties; 2.3.2 . Mechanical Properties; 2.3.3 . Optical Properties; 2.3.4 . Electrical Properties; 2.4 . Surface Characterization; 2.4.1 . Microscopic Characterization; 2.4.2 . Surface Hydrophobicity; 2.4.3 . Spectroscopic Characterization; 2.5 . Future Prospects; References; Chapter 3: Proteins and Poly(Amino Acids); 3.1 . Introduction; 3.2 . Fibrin-Based Biomaterials.
|
| 505 |
8 |
|
|a 3.3 . Elastin-Based Biomaterials3.4 . Silk-Based Biomaterials; 3.5 . Collagen-Based Biomaterials; 3.6 . Poly(glutamic Acid)-Based Biomaterials; 3.7 . Cyanophycin and Poly(Aspartic Acid)-Based Biomaterials; 3.8 . Poly- l -Lysine-Based Biomaterials; 3.9 . Conclusions and Future Work; References; Chapter 4: Natural Polymers: Polysaccharides and Their Derivatives for Biomedical Applications; 4.1 . Introduction; 4.2 . Hyaluronic Acid; 4.2.1 . Chemical Structure, Properties, and Sources; 4.2.2 . Attempts Made in Tissue Engineering and Drug Delivery; 4.2.2.1 . HA Alone.
|
| 500 |
|
|
|a 4.2.2.2 . HA Derivatives and Combinations with Other Polymers.
|
| 520 |
|
|
|a Polymers are important and attractive biomaterials for researchers and clinical applications due to the ease of tailoring their chemical, physical and biological properties for target devices. Due to this versatility they are rapidly replacing other classes of biomaterials such as ceramics or metals. As a result, the demand for biomedical polymers has grown exponentially and supports a diverse and highly monetized research community. Currently worth 1.2bn in 2009 (up from 650m in 2000), biomedical polymers are expected to achieve a CAGR of 9.8% until 2015, supporting a current research co.
|
| 546 |
|
|
|a English.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Biopolymers.
|
| 650 |
|
0 |
|a Biodegradable plastics.
|
| 650 |
|
0 |
|a Polymers.
|
| 650 |
|
0 |
|a Manufactures.
|
| 650 |
|
0 |
|a Biomedical materials.
|
| 650 |
|
7 |
|a polymers.
|2 aat
|
| 650 |
|
7 |
|a Polymers
|2 fast
|
| 650 |
|
7 |
|a Manufactures
|2 fast
|
| 650 |
|
7 |
|a Biomedical materials
|2 fast
|
| 650 |
|
7 |
|a Biodegradable plastics
|2 fast
|
| 650 |
|
7 |
|a Biopolymers
|2 fast
|
| 700 |
1 |
|
|a Laurencin, Cato.
|
| 700 |
1 |
|
|a Deng, Meng.
|
| 776 |
0 |
8 |
|i Print version:
|t Natural and synthetic biomedical polymers.
|b First edition.
|d Burlington, Massachusetts ; San Diego, California : Elsevier, ©2014
|h xvii, 402 pages
|z 9780123969835
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=1619549
|y Click for online access
|
| 880 |
8 |
|
|6 505-01/(S
|a 5.5.2 . Chitosan-Based Scaffolds for Tissue Engineering Applications -- 5.5.2.1 . Bone -- 5.5.2.2 . Cartilage -- 5.5.2.3 . Skin -- 5.5.2.4 . Intervertebral Disc -- 5.5.2.5 . Other Soft Tissues -- 5.6 . Chitosan Application in Drug Delivery -- 5.7 . Conclusions -- Acknowledgments -- References -- Chapter 6: Poly(α -ester)s -- 6.1 . Advantages of Absorbable Poly(α -Ester)s -- 6.2 . Polylactides, Polyglycolides, and Copolymers Thereof -- 6.2.1 . Structure and Characteristics -- 6.2.2 . Processing -- 6.3 . Bacterial and Other Recombinant Polyesters -- 6.3.1 . Structure and Characteristics -- 6.3.2 . Processing -- References -- Chapter 7: Polyurethanes -- 7.1 . Introduction -- 7.2 . Synthesis and Characterization -- 7.2.1 . Synthesis -- 7.2.2 . Characterization -- 7.3 . Impact of Composition on Polyurethane Properties -- 7.3.1 . Poly(Ether Urethanes) -- 7.3.2 . Poly(Carbonate Urethanes) -- 7.3.3 . Poly(Ether Ester Urethanes) -- 7.3.4 . Poly(Siloxane Urethanes) -- 7.3.5 . Polyurethane and Natural Polymers -- 7.3.6 . Polyurethane Composites -- 7.3.7 . Surface-Modified Polyurethanes -- 7.4 . Phase Separation Behavior -- 7.5 . Calcification -- 7.6 . Polyurethane Applications -- 7.6.1 . Drug Delivery -- 7.6.2 . Tissue Engineering -- 7.6.3 . Polyurethane Medical Devices -- 7.7 . Conclusion -- Acknowledgments -- References -- Chapter 8: Poly(Ester Amide)s: Recent Developments on Synthesis and Applications -- 8.1 . Introduction -- 8.2 . Synthesis of PEAs -- 8.3 . Design of PEAs with a Given Microstructure -- 8.3.1 . Hyperbranched PEAs -- 8.4 . Liquid Crystals and Rigid-Chain PEAs -- 8.5 . PEAs from Renewable Sources -- 8.5.1 . Carbohydrate Derivatives -- 8.5.2 . PEAs from Vegetable Oils and Fatty Diacids -- 8.5.3 . PEAs Derived from α -Amino Acids and Their Applications in the Biomedical Field -- 8.6 . Miscellaneous Applications of PEAs.
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|